Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Granules India
Manufacturing
Granules recalls blood pressure med for failing to meet specs
Granules has issued a voluntary recall of the high blood pressure treatment metoprolol succinate, citing failed stability study results.
Joseph Keenan
Jul 9, 2025 8:46am
Granules hit with FDA warning letter over production woes
Mar 5, 2025 8:38am
Granules buys Senn Chemicals for $22M to enter peptides biz
Feb 24, 2025 8:38am
Granules receives Form 483 over poor document controls and more
Sep 19, 2024 10:11am
FDA issues Granules India 3 observations after inspection
Jan 31, 2022 10:20am
Marksans dramatically expands metformin recall on NDMA scare
Oct 5, 2020 6:18pm